HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

In Brief: Dep

This article was originally published in The Rose Sheet

Executive Summary

Dep: Posts $28.5 mil. in sales for FY 1998 second quarter (ended Jan. 31), a decline from $29.1 mil. in the year-ago period, the company reported Feb. 24. Quarterly income jumped to $770,000 from $64,000 in FY 1997. For the half, sales slipped 4.9% to $54.3 mil., but the company reported earnings of $1.3 mil., compared to a $2 mil. loss in FY 1997. The company attributed the slip in sales to the conversion process in its China and Australia markets as operations move from direct sales markets to distributorships. The second quarter marks Dep's third consecutive profitable three-month period since the firm emerged from bankruptcy. In March, Dep will have repaid its debt to unsecured creditors in full...

Latest Headlines
See All
UsernamePublicRestriction

Register

RS005159

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel